Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 5, 2021 - Issue 2
Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis

Masahiro NishiharaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Marina HamaguchiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Natsumi IkumiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Atsuma NishiwakiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Kaita SugiyamaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Yosuke NagasawaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Hiroshi TsuzukiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Shoei YoshizawaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Yutaka TanikawaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Shinya AsataniDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Hitomi KobayashiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Masami TakeiDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanView further author information
&
Noboru KitamuraDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, JapanCorrespondence[email protected]
View further author information
 show all
Pages 354-359 | Received 04 Dec 2020, Accepted 07 Apr 2021, Published online: 10 May 2021

References

  • Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine. 1999;78(1):26–37.
  • Giusti Del Giardino L, Cavallaro T, Anzola GP, et al. Neuropathy in eosinophilic granulomatosis with polyangiitis: a comparison study of 24 cases with or without prior leukotriene antagonist exposure. Eur Ann Allergy Clin Immunol. 2014;46(6):201–209.
  • Baldini C, Talarico R, Della Rossa A, et al. Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am. 2010;36(3):527–543.
  • Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017;376(20):1921–1932.
  • Steinfeld J, Bradford ES, Brown J, et al. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol. 2019;143(6):2170–2177.
  • Suzuki K, Birnbaum Z, Lockhart R. Skin perfusion pressure and wound closure time in lower extremity wounds. J Am Coll Clin Wound Spec. 2018;9(1–3):14–18.
  • Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–1100.
  • Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671–678.
  • Guillevin L, Pagnoux C, Seror R, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine. 2011;90(1):19–27.
  • Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005;52(9):2926–2635.
  • Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–317.
  • Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545–353.
  • Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine. 1996;75:17–28.
  • Koike H, Akiyama K, Saito T, et al. Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial. J Neurol. 2015;262(3):752–729.
  • Yasuda M, Sugiyama A, Suichi T, et al. Marked neurological and immunological improvement in refractory eosinophilic granulomatous polyangiitis after treatment with mepolizumab, an anti‐interleukin‐5 antibody: a case report. Clin Exp Neuroimmunol. 2020;11(3):181–184.
  • Tsurikisawa N, Taniguchi M, Saito H, et al. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol. 2004;92(1):80–87.
  • Nishi R, Koike H, Ohyama K, et al. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA. Neurology. 2020;94(16):e1726–e1737.
  • Zhang Z, Liu S, Guo L, et al. Clinical characteristics of peripheral neuropathy in eosinophilic granulomatosis with polyangiitis: a retrospective single-center study in China. J Immunol Res. 2020;2020:1–10.
  • Kitamura N, Nishihara M, Takei M, et al. The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients. Allergol Int. 2020;70(1):148–149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.